University of Tennessee Health Science Center Campus Photos
OWA WebMail  /  SiteMap  /  Contact Information

Marion Dugdale, M.D.

Position
Professor of Medicine/Hematology; Director, Hemophilia Clinic

Education / Training
  • Bryn Mawr College - B.A. (Magna Cum Laude); 1947-1950
  • Harvard Medical School - M.D. (Alpha Omega Alpha); 1950-1954
  • Internship and Residency: University of North Carolina Memorial Hospital, Chapel Hill, NC; 1954-1957
  • Assistant Resident in Pathology (Coagulation), University of North Carolina Medical School, Chapel Hill, North Carolina; 1958
  • Fellowship in Hematology, American Cancer Society, Duke Hospital, Durham, NC; 1957-1958
  • Resident in Medicine-Hematology, Department of Medical Labs, UT Memphis; 1958-1959
  • Research Fellow in Hematology, UT Memphis; Oct. 1959-Sept. 1962

Professional Positions
  • Instructor in Medicine, Division of Hematology, University of Tennessee, Memphis; 1962-1963
  • Assistant Professor of Medicine, Division of Hematology, University of Tennessee; 1963-1968
  • Associate Professor of Medicine, Division of Hematology, University of Tennessee; 1968-1973
  • Director, UT Hemophilia Clinic, Van Vleet Cancer Center, University of Tennessee; 1972-Present
  • Professor of Medicine, Division of Hematology, University of Tennessee; 1973-Present
  • Member, Advisory Committee of the Tennessee State Hemophilia Program

Honors
  • Humanitarian Award, Memphis Chapter, National Hemophilia Foundation, 1977
  • Distinguished Teaching Award (Pathophysiology), 1981-1982
  • Gene H. Stollerman Outstanding Faculty Teaching Award, 1981 & 1985
  • President, UT/Bowld Hospital, 1986
  • President, College of Medicine Faculty Organization, 1986-1987
  • Award of Appreciation (Outstanding lecturer, Class of '87)
  • National Hemophilia Foundation, Special Award for Commitment to the Improvement of Hemophilia Care in West Tennessee, 1987
  • Distinguished Service Award, UT/Bowld Hospital, 1988
  • Memphis Chapter, National Hemophilia Foundation, The Marion Dugdale Scholarship Fund, 1988
  • Clinical Teaching Award, 1989
  • Best Lecturer (Medical Student Executive Council), 1992
  • Golden Apple Teaching Award, 1992
  • Service to the Adult Hemophilia Community of Memphis, 1993
  • Regional Medical Center at Memphis Distinguished Service, 1994
  • National Alumni Distinguished Professor, 1997
  • Alumni Distinguished Service Professor, 1999
  • Member, American Society of Hematology
  • Member, International Society of Thrombosis and Hemostasis
  • Member, National Hemophilia Foundation
  • Member, World Federation of Hemophilia

Research Support

Member of cooperative project groups:
  • CDC - "Hemophilia - Natural History of Joint Disease and Liver Disease
  • NIH - "Hemophilia - Liver Disease in HIV-positive Patients, Incidence of Malignancy"

Relevant Publications
  1. Diggs, L. W. and Dugdale, M.: Hemorrhagic and Thromboembolic Diseases. In a Textbook of Clinical Pathology. 7th Ed. Seward E. Miller, 1966.
  2. Dugdale, M.: Disorders of Hemostasis. In a Textbook of Clinical Pathology. 8th Ed. Seward E. Miller, Editor; Williams and Wilkins, Baltimore, 1971.
  3. Dugdale, M.: Clinical Use of Sex Steroids. James R. Givens Year Book Medical Publishers, Inc., 1980
  4. Dugdale, M.: Coagulation and Hematology during Liver Transplantation in. In, Hepatic Transplantation in Cyclosporine era: An Emphasis on Histopathology. James W. Williams. W.B. Saunders Company, Philadelphia, 1989.
  5. Lasslo, A., Dugdale, M., Dillingham, E.O., Gollamudi, R. and Lawrence, W.H.: Surface-Active Antithrombotic Agents for Prostheses. Cardiovascular Science & Technology: Basic & Applied, I, Oxymoron Press, 1989.
  6. Dugdale, M.: Anticoagulants, Antithrombotis and Thrombolytic Agents. In Biochemical Pharmacology of Blood and Bloodforming Organs. Ed. James W. Fisher Springer-Verlag, Berlin, 1992.
  7. Neft, L.G., Dugdale, M., Biggs, A.W., and Raines, S.L.: Treatment of Abnormal Bleeding Associated with Prostatic Disease by Intravenous Fat Emulsion. J. of Urol. 85:329-333, March, 1961.
  8. Diggs, L.W. and Dugdale, M.: Series of articles on "Blood Coagulation" published in consecutive issues of the Memphis and Mid-South Medical Journal and representing material presented at a workshop dealing with tests used in hemorrhagic and thrombotic diseases. 1 Blood Coagulation. 37:283, June, 1962
  9. Dugdale, M.: II General Principles of Hemostasis. 37:337, July, 1962.
  10. Dugdale, M.: VI Platelets and Platelet Function. 37:421, October, 1962.
  11. Dugdale, M.: VII Blood Coagulation. 37:499, December, 1962.
  12. Dugdale, M.: VIII Blood Coagulation. 37, January, 1963.
  13. Dugdale, M.: IX Fibrinolytic System. 37, February, 1963.
  14. Pate, J.W. and Dugdale, M.: Coagulation Studies on Blood from the Right and Left Sides of the Heart. Am. J. Surg. 107(6), June, 1964.
  15. Dugdale, M.: Multiple Myeloma. Filmstrip with Accompanying Booklet Presented at the Meeting of the Am. Acad. of Ortho. Surg., Film 42, 1965.
  16. Dugdale, M.: Myeloma Multiple. Filmstrip in Spanish for the Am. Acad. of Ortho. Surg. Meeting, 1966.
  17. Dugdale, M., Nofzinger, J.D., Murphey, F.: Some Effects of Low Molecular Weight Dextran on Coagulation. Thrombosis et Diathesis Haemorrhagica. XV, 1966.
  18. Dugdale, M. and Fort, A.T.: Busulfan Treatment of Leukemia During Pregnancy. JAMA 199: 176, 1967.
  19. Dugdale, M. and Masi, A.T.: Effects of Oral Contraceptives on Blood Clotting. Second Report on the Oral Contraceptives, Advisory Committee on Obstetrics and Gynecology, Washington, D.C., FDA, pp. 43-51, 1969.
  20. Dugdale, M.: The Platelet and Hypothermia. Blood 34: 532-533, 1969.
  21. Masi, A.T. and Dugdale, M.: Cerebrovascular Diseases Associated with the Use of Oral Contraceptives. Annals of IM 72(1):111-121, January 1970.
  22. Dugdale, M. and Masi, A.T.: Hormonal Contraception and Thromboembolic Disease: Effects of the Oral Contraceptives on Hemostatic Mechanisms. J. Chronic. Dis. 23:775-790, 1971.
  23. Denton, I.C., Robertson, J.T., and Dugdale, M.: Assessment of Early Platelet Activity in Experimental Subarachnoid Hemorrhage and Middle Cerebral Artery Occlusion in the Cat. Stroke 2: 268-272, 1971.)
  24. Salky, N., and Dugdale, M.: Platelet Abnormalities in Ischemia Heart Disease. Am. J. Cardiology 32: 612-617, 1973. Morgan, H., Nofzinger, J.D., Robertson, J.T., and Dugdale, M.: Hemorrhagic Studies with Severe Hemodilution in Profound Hypothermia
  25. and Cardiac Arrest. J. Surg. Res. 14: 459-464, 1973.
  26. Morrison, J.C., Ellis, G., Jones, T., Wiser, W.L., Whybrew, W.D., Bucovaz, E.T., Dugdale, M., and Fish, S.A.: The Effects of Antibiotics on Serum Fibrinogen Levels. Obstetrics and Gynecology 42: 80-86, 1973.
  27. Dugdale, M.: Effects of the Oral Contraceptives on the Vascular System. Vol. 1: Pharmacology and the Future of Man Proceedings of the 5th Int. Congress on Pharmacology, San Francisco, 1972, pp. 260-268. S. Karger, Basel, Switzerland, 1973.
  28. Quintana, R.P., Dugdale, M., and Lasslo A.: Dynamics of Human Blood Platelets Membrane Integrity. Throm. Res. 16:543-550, 1979.
  29. White, R.P., Chapleau, C.E, Dugdale, M., and Robertson, J.T.: Cerebral Arterial Contractions Induced by Human and Bovine Thrombin. Stroke 11(4): 363-368, 1980.
  30. Dugdale, M.: Side Effects of Sex Steroid Therapy: Clotting and Platelet functions. Year Book Medical Publishers, Inc., 1980.
  31. Quintana, Ronald P., Lasslo, A., Dugdale, M. Goodin, Lisa L., and Burkhardt, Eric F.: Effects of Ethanol and of Other Factors on ADP-Induced Aggregation of Human Blood Platelets In Vitro. Thrombosis Research 20: 403-415, 1980.
  32. Quintana, R.P., Lasslo, A., Dugdale, M., and Goodin, L.L.: Relationships Between the Chemical Constitution of Carbamoylpeperidines and Related Compounds, and Their Inhibition of ADP-Induced Human Blood Platelet Aggregation. Thrombosis Research 22:665-680, 1981.
  33. Quintana, R.P., Lasslo, A., and Dugdale, M.: Human Blood Platelet Aggregation Inhibitory Target Sites Assumed to Involve Membrane Phospholipids. Biophysical Society, Volume 37, January, 1982.
  34. Lasslo, A., Quintana, R.P., Dugdale, M., Johnson, R.W., and Naylor, J.L.: Development of Novel Surface-Active Compounds for prophylaxis Against and Treatment of Thromboembolic Complications. American Society for Artificial Internal Organs. April-June, 1982.
  35. Dugdale, M. and Smith, R.M.: The Patient with Bleeding Problems. Dental Clinics of North America 27(2): 271-288, 1983.
  36. Lasslo, A., Quintana, R.P., Dugdale, M., Johnson, R.W., and Naylor, J.L.: Development of Novel Surface-Active Compounds for Prophylaxis Against and Treatment of Thromboembolic Complications. ASAIO, 6(2):47-59, 1983.
  37. Lasslo, A, Quintana, R.P., Johnson, Randy W., Naylor, Jen L., and Dugdale, M.: Relationships between the chemical constitution of aggregation inhibitors and human blood platelet response profile. Biochimica et Biophysica Acta, 772:84-92, 1984.\
  38. Williams, J.A., Presbury, G., Orenstein, D., Dahl, G., Wang, W., Dugdale, M.: Hemothorax and Hemomediastinum in Patients with Hemophilia. Acta. Haemat. 73:176-178, 1985.
  39. Jason, J., Holman, R.C., Dixon, G., et. al., and The Hemophilia/AIDS Collaborative Study Group: Effects of Exposure to Factor Concentrates Containing Donations from Identified AIDS Patients. J. Amer. Med. Assn. 256:1758-1762, 1986.
  40. Canale, S.T., Dugdale, M., and Howard, B.C.: Synovectomy of the Knee in Young Patients with Hemophilia. Southern Medical Journal, 81(12):1480-1486, 1988
  41. Dugdale, M., Britt, Louis G., Vera, S.R., et at.: Identification of the nature of hemostatic failure during transplantation of the liver. Transplantation Proceedings, Vol 21, No. 1, 1989, 2332-2333.
  42. Hughes, W.T., Kennedy, W., Dugdale, M., Land, M.A., Stein, D.S., et. al: Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone. Lancet. 1066, October 27, 1990
  43. Deitcher SR, Tuller J, and Dugdale M.: Effect of intermediate- and high-purity factor VIII concentrates on immune function in HIV seropositive hemophiliacs as assessed by quantitative CD4 count. Haemophila (in press).
  44. Deitcher S, Johnson J, Tuller J, Cholera S, Crawford D, and Dugdale M.: Intranasal DDAVP induced increases in plasma von Willebrand factor (vWf) alter the pharmacokinetics of high-purity factor VIII (FVIII) concentrates in severe hemophilia A patients. Haemophilia 2 (Supplement 1), 13, 1996.
  45. Guo Z, Zheng X, Thompson W, Dugdale M, and Gollamudi: New carbamoylpiperidiiines as human plaelet aggregation inhibitors. Bioorganic & Medicinal Chemistry 8 (2000) 1041-1058.
  46. Sallah, S, Dugdale, M., Chesney, C, Wan, I. And Roberts, R.: Inhibitors against factor VIII in patients with underlying malignancy: a clinicopathologic study. Haemophilia (2000), 6, 279-314.